Cited by 444Hormonal and reproductive studiesCardiovascular and exercise physiologyHeart Failure Treatment and Management

Effect of Long-Acting Testosterone Treatment on Functional Exercise Capacity, Skeletal Muscle Performance, Insulin Resistance, and Baroreflex Sensitivity in Elderly Patients With Chronic Heart Failure

Open access
Caminiti, Giuseppe, Volterrani, Maurizio, Iellamo, Ferdinando, Marazzi, Giuseppe, Massaro, Rosalba, Miceli, Marco, Mammi, Caterina, Piepoli, Massimo +2 more·2009·Journal of the American College of Cardiology

Abstract

Objectives This study investigated the effect of a 12-week long-acting testosterone administration on maximal exercise capacity, ventilatory efficiency, muscle strength, insulin resistance, and baroreflex sensitivity (BRS) in elderly patients with chronic heart failure (CHF).Background CHF is characterized by a metabolic shift favoring catabolism and impairment in skeletal muscle bulk and function that could be involved in the pathophysiology of heart failure.Methods Seventy elderly patients with stable CHF-median age 70 years, ejection fraction 31.8 +/- 7%-were randomly assigned to receive testosterone (n = 35, intramuscular injection every 6 weeks) or placebo (n = 35), both on top of optimal medical therapy. At baseline and at the end of the study, all patients underwent echocardiogram, cardiopulmonary exercise test, 6-min walk test (6MWT), quadriceps maximal voluntary contraction (MVC), and isokinetic strength (peak torque) and BRS assessment (sequences technique).Results Baseline peak oxygen consumption (VO(2)) and quadriceps isometric strength showed a direct relation with serum testosterone concentration. Peak VO(2) significantly improved in testosterone but was unchanged in placebo. Insulin sensitivity was significantly improved in testosterone. The MVC and peak torque significantly increased in testosterone but not in placebo. The BRS significantly improved in testosterone but not in placebo. Increase in testosterone levels was significantly related to improvement in peak VO(2) and MVC. There were no significant changes in left ventricular function either in testosterone or placebo.Conclusions These results suggest that long-acting testosterone therapy improves exercise capacity, muscle strength, glucose metabolism, and BRS in men with moderately severe CHF. Testosterone benefits seem to be mediated by metabolic and peripheral effects.

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2009.04.078

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A 12-week long-acting testosterone administration increases quadriceps isometric strength, maximal voluntary contraction, and isokinetic strength.

    “A study investigating the effect of a 12-week long-acting testosterone administration on maximal exercise capacity and muscle strength found an increase in quadriceps isometric strength, maximal voluntary contraction, and isokinetic strength (peak torque) (12).”
  • Changes in fat mass, lean body mass, and muscle strength occur within 12-16 weeks of testosterone treatment.

    “Changes in fat mass, lean body mass, and muscle strength occur within 12–16 weeks, stabilize at 6–12 months, but can marginally continue over years.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Caminiti, G., Volterrani, M., Iellamo, F., Marazzi, G., Massaro, R., Miceli, M., Mammi, C., Piepoli, M., Fini, M., & Rosano, G. M. C.
Affiliations
  • Istituti di Ricovero e Cura a Carattere Scientifico (IT)
  • University of Rome Tor Vergata (IT)
  • Guglielmo da Saliceto Hospital (IT)
Corresponding author
Iellamo, Ferdinando
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2009-09
Volume
54
Issue
10
Pages
919-927
ISSN
0735-1097 (ISSN-L)
OpenAlex
W176571599
Cited by
444
References
51
Citations by year
2026: 9 · 2025: 13 · 2024: 12 · 2023: 13 · 2022: 24 · 2021: 28 · 2020: 28 · 2019: 23 · 2018: 25 · 2017: 24 · 2016: 29 · 2015: 34 · 2014: 48 · 2013: 27 · 2012: 31
FWCI
25.90
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
  • Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Complementary and alternative medicine › Cardiovascular and exercise physiology
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Keywords
testosterone replacement therapy, chronic heart failure, older men, exercise capacity, skeletal muscle strength, insulin resistance, baroreflex sensitivity, peak oxygen uptake, ventilatory efficiency, left ventricular function
MeSH terms
Aged, Blood Glucose, Chronic Disease, Double-Blind Method, Echocardiography, Exercise Test, Heart Failure, Humans, Injections, Intramuscular, Insulin Resistance, Leg, Male, Oxygen Consumption, Testosterone, Ventricular Function, Left, Exercise Tolerance, Baroreflex, Muscle, Skeletal, Testosterone Congeners, Muscle Strength

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review